These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12966435)

  • 21. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors.
    Sakai T; Kambe F; Mitsuyama H; Ishiguro N; Kurokouchi K; Takigawa M; Iwata H; Seo H
    J Bone Miner Res; 2001 Jul; 16(7):1272-80. PubMed ID: 11450703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducible NF-kappaB activation is permitted by simultaneous degradation of nuclear IkappaBalpha.
    Renard P; Percherancier Y; Kroll M; Thomas D; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
    J Biol Chem; 2000 May; 275(20):15193-9. PubMed ID: 10809754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events.
    Huang TT; Wuerzberger-Davis SM; Seufzer BJ; Shumway SD; Kurama T; Boothman DA; Miyamoto S
    J Biol Chem; 2000 Mar; 275(13):9501-9. PubMed ID: 10734098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.
    Palombella VJ; Conner EM; Fuseler JW; Destree A; Davis JM; Laroux FS; Wolf RE; Huang J; Brand S; Elliott PJ; Lazarus D; McCormack T; Parent L; Stein R; Adams J; Grisham MB
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15671-6. PubMed ID: 9861028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy.
    Tergaonkar V; Bottero V; Ikawa M; Li Q; Verma IM
    Mol Cell Biol; 2003 Nov; 23(22):8070-83. PubMed ID: 14585967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
    Roff M; Thompson J; Rodriguez MS; Jacque JM; Baleux F; Arenzana-Seisdedos F; Hay RT
    J Biol Chem; 1996 Mar; 271(13):7844-50. PubMed ID: 8631829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leucine modulates the effect of Walker factor, a proteolysis-inducing factor-like protein from Walker tumours, on gene expression and cellular activity in C2C12 myotubes.
    Gonçalves EM; Salomão EM; Gomes-Marcondes MC
    Cytokine; 2013 Oct; 64(1):343-50. PubMed ID: 23746792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of induction of muscle protein degradation by angiotensin II.
    Russell ST; Wyke SM; Tisdale MJ
    Cell Signal; 2006 Jul; 18(7):1087-96. PubMed ID: 16257180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibitors induce inhibitory kappa B (I kappa B) kinase activation, I kappa B alpha degradation, and nuclear factor kappa B activation in HT-29 cells.
    Németh ZH; Wong HR; Odoms K; Deitch EA; Szabó C; Vizi ES; Haskó G
    Mol Pharmacol; 2004 Feb; 65(2):342-9. PubMed ID: 14742676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway.
    Tanaka K; Kawakami T; Tateishi K; Yashiroda H; Chiba T
    Biochimie; 2001; 83(3-4):351-6. PubMed ID: 11295496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
    Whitehouse AS; Tisdale MJ
    Biochem Biophys Res Commun; 2001 Jul; 285(3):598-602. PubMed ID: 11453634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB.
    Weigert C; Brodbeck K; Staiger H; Kausch C; Machicao F; Häring HU; Schleicher ED
    J Biol Chem; 2004 Jun; 279(23):23942-52. PubMed ID: 15028733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome.
    Kroll M; Arenzana-Seisdedos F; Bachelerie F; Thomas D; Friguet B; Conconi M
    Chem Biol; 1999 Oct; 6(10):689-98. PubMed ID: 10508680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of IkappaB-alpha and IkappaB-beta proteolysis by calpain inhibitor I blocks nitric oxide synthesis.
    Milligan SA; Owens MW; Grisham MB
    Arch Biochem Biophys; 1996 Nov; 335(2):388-95. PubMed ID: 8914937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A MEK inhibitor, PD98059 enhances IL-1-induced NF-kappaB activation by the enhanced and sustained degradation of IkappaBalpha.
    Funakoshi M; Tago K; Sonoda Y; Tominaga S; Kasahara T
    Biochem Biophys Res Commun; 2001 Apr; 283(1):248-54. PubMed ID: 11322796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
    Sanders PM; Russell ST; Tisdale MJ
    Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
    Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M
    J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.
    Saccani S; Marazzi I; Beg AA; Natoli G
    J Exp Med; 2004 Jul; 200(1):107-13. PubMed ID: 15226358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.